
KYMERA THERAPEUTICS INC
KYMRNASDAQ๐ #825 by market capEarnings Nov 2US Equity
$109.65โฒ $1.07 (+0.98%)
๐
Pre-market$110.50โฒ 0.78%Regular close ยท extended-hours price shown1hโ
24hโฒ 1.0%
7dโฒ 4.0%
14dโฒ 4.2%
30dโผ 0.7%
1yโฒ 174.9%
๐ฆMarket Cap
$9.02B
Small Cap
๐Revenue Growth (YoY)
+134.8%
High Growth
๐Gross Margin
โ
๐ตFCF Margin
โ
โ๏ธP/S Ratio
86.0x
Expensive
Otter Score
43
Weak
Earnings
Q3 ยท 2026Reported 2026-08-05Earnings Per Share
Actual
-0.62
Expected
-0.71
beat
+13.00%
YoY +34.70%
Revenue
Actual
$65.00M
Expected
$32.78M
beat
+98.30%
YoY +466.40%
Consensus estimates
Recent quarters
Q3 2026
-0.62
beat
Q2 2026
-0.71
beat
Q1 2026
-0.97
miss
Q4 2025
-0.90
miss